BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Nurandociguat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Nurandociguat\, from ClinicalTrials.gov e
 stimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07431294-583@assetmemo.bio
DTSTAMP:20261121T004120Z
DTSTART;VALUE=DATE:20270507
DTEND;VALUE=DATE:20270508
SUMMARY:Nurandociguat: Phase 1 readout est. (NCT07431294)
DESCRIPTION:Nurandociguat\, phase 1.\nStudy: A Study to Learn About How Saf
 e Nitroglycerin is and How it Affects the Body When Taken Along With Nuran
 dociguat in People With Coronary Artery Disease\nEstimated primary complet
 ion: 7 May 2027. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/nura
 ndociguat#upcoming-events\nRegistry record: https://clinicaltrials.gov/stu
 dy/NCT07431294
URL:https://assetmemo.bio/drug/nurandociguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
